Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The researchers focused on a class of drugs called GLP-1 receptor agonists
However, clinical trials in chronic heart failure with reduced ejection fraction (HFrEF), such as the LIVE trial, have yielded mixed or modestly negative results
But in March, the FDA approved Wegovy to reduce cardiovascular risk in overweight people, after a clinical study showed the drug cut the risk of heart attacks and strokes by as much as 20 percent for overweight people with a history of heart disease
The full warnings and precautions section is longer than this article can responsibly summarize, and reading the Medication Guide that came with your prescription is the right move
:max_bytes(150000):strip_icc()/Common-Symptoms-From-Taking-a-GLP-1-And-How-to-Manage-Them-9e5bb7cee0484522a50dd9d7ce954cc4.jpg)
